These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 10397258

  • 1. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O, Aurias A.
    Cancer Res; 1999 Jul 01; 59(13):3152-6. PubMed ID: 10397258
    [Abstract] [Full Text] [Related]

  • 2. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB.
    Clin Cancer Res; 2002 Nov 01; 8(11):3461-7. PubMed ID: 12429635
    [Abstract] [Full Text] [Related]

  • 3. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H, Misaki K, Takabatake Y, Hasegawa M, Yamashita J.
    J Neurooncol; 2005 Jun 01; 73(2):117-24. PubMed ID: 15981100
    [Abstract] [Full Text] [Related]

  • 4. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, Pierron G, Sainte-Rose C, Bergeron C, Bouvier R, Rialland X, Laurence V, Michon J, Sastre-Garau X, Delattre O.
    J Pathol; 2007 Feb 01; 211(3):323-30. PubMed ID: 17152049
    [Abstract] [Full Text] [Related]

  • 5. Chromosome mechanisms and INI1 inactivation in human and mouse rhabdoid tumors.
    Rousseau-Merck MF, Fiette L, Klochendler-Yeivin A, Delattre O, Aurias A.
    Cancer Genet Cytogenet; 2005 Mar 01; 157(2):127-33. PubMed ID: 15721633
    [Abstract] [Full Text] [Related]

  • 6. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
    Uno K, Takita J, Yokomori K, Tanaka Y, Ohta S, Shimada H, Gilles FH, Sugita K, Abe S, Sako M, Hashizume K, Hayashi Y.
    Genes Chromosomes Cancer; 2002 May 01; 34(1):33-41. PubMed ID: 11921280
    [Abstract] [Full Text] [Related]

  • 7. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
    Versteege I, Sévenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O.
    Nature; 1998 Jul 09; 394(6689):203-6. PubMed ID: 9671307
    [Abstract] [Full Text] [Related]

  • 8. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T, Miao J, Yoneda A, Kuroda S, Fukuzawa M.
    Genes Chromosomes Cancer; 2004 Jun 09; 40(2):133-9. PubMed ID: 15101046
    [Abstract] [Full Text] [Related]

  • 9. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
    Sévenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O.
    Hum Mol Genet; 1999 Dec 09; 8(13):2359-68. PubMed ID: 10556283
    [Abstract] [Full Text] [Related]

  • 10. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S, Cimica V, Ramachandra N, Zagzag D, Kalpana GV.
    Cancer Res; 2011 May 01; 71(9):3225-35. PubMed ID: 21521802
    [Abstract] [Full Text] [Related]

  • 11. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
    Kraus JA, de Millas W, Sörensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A, Pietsch T.
    Acta Neuropathol; 2001 Jul 01; 102(1):69-74. PubMed ID: 11547953
    [Abstract] [Full Text] [Related]

  • 12. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
    Kraus JA, Oster C, Sörensen N, Berthold F, Schlegel U, Tonn JC, Wiestler OD, Pietsch T.
    Neuropathol Appl Neurobiol; 2002 Apr 01; 28(2):136-41. PubMed ID: 11972800
    [Abstract] [Full Text] [Related]

  • 13. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
    Zhang F, Tan L, Wainwright LM, Bartolomei MS, Biegel JA.
    Genes Chromosomes Cancer; 2002 Aug 01; 34(4):398-405. PubMed ID: 12112529
    [Abstract] [Full Text] [Related]

  • 14. Two single nucleotide polymorphisms of the hSNF5/INI1 gene.
    Mine N, Bando K, Utada Y, Nagai H, Araki T, Emi M.
    J Hum Genet; 1999 Aug 01; 44(5):354-5. PubMed ID: 10496084
    [Abstract] [Full Text] [Related]

  • 15. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
    Grand F, Kulkarni S, Chase A, Goldman JM, Gordon M, Cross NC.
    Cancer Res; 1999 Aug 15; 59(16):3870-4. PubMed ID: 10463572
    [Abstract] [Full Text] [Related]

  • 16. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, Sozzi G.
    Cancer Res; 2005 May 15; 65(10):4012-9. PubMed ID: 15899790
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
    Fujisawa H, Takabatake Y, Fukusato T, Tachibana O, Tsuchiya Y, Yamashita J.
    J Neurooncol; 2003 Jul 15; 63(3):257-62. PubMed ID: 12892231
    [Abstract] [Full Text] [Related]

  • 18. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M, Isken S, Linge A, Eikmeier K, Jeibmann A, Oyen F, Nagel I, Richter J, Bartelheim K, Kordes U, Schneppenheim R, Frühwald M, Siebert R, Paulus W.
    Genes Chromosomes Cancer; 2013 Feb 15; 52(2):185-90. PubMed ID: 23074045
    [Abstract] [Full Text] [Related]

  • 19. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.
    Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A.
    Brain Pathol; 2005 Jan 15; 15(1):23-8. PubMed ID: 15779233
    [Abstract] [Full Text] [Related]

  • 20. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
    Kuroda H, Moritake H, Sawada K, Kuwahara Y, Imoto I, Inazawa J, Sugimoto T.
    Cancer Genet Cytogenet; 2005 Apr 15; 158(2):172-9. PubMed ID: 15796965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.